Related Experiment Video
Updated: Jun 10, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
[Type 2 diabetes mellitus as a subclinical inflammation]
1Univerzita Karlova v Praze, 1. lékarská fakulta, III. interní klinika VFN. jan.skrha@lf1.cuni.cz
Type 2 diabetes mellitus arises from genetic and external factors, involving oxidative stress and subclinical inflammation. Understanding these mechanisms offers new avenues for diabetes treatment and prevention strategies.
Area of Science:
- Endocrinology
- Immunology
- Metabolic Syndrome
Context:
- Type 2 diabetes mellitus (T2DM) pathogenesis involves intricate interactions between genetic predisposition and environmental influences.
- Metabolic dysregulation and increased oxidative stress are key contributors to T2DM development.
- Subclinical inflammation, arising from anti-inflammatory responses, plays a critical role in T2DM pathophysiology.
Purpose:
- To elucidate the combined roles of genetic background and external factors in Type 2 diabetes mellitus development.
- To investigate the contribution of oxidative stress and complex inflammatory reactions to T2DM pathogenesis.
- To explore novel therapeutic and preventive strategies for Type 2 diabetes mellitus based on its underlying mechanisms.
Summary:
- Type 2 diabetes mellitus develops due to a combination of genetic susceptibility and environmental triggers.
- Increased oxidative stress and a complex, subclinical inflammatory response are central to T2DM disease progression.
- The understanding of T2DM as a consequence of defensive anti-inflammatory reactions opens new therapeutic and preventive possibilities.
Impact:
- Provides a comprehensive understanding of Type 2 diabetes mellitus etiology, integrating genetic, metabolic, and inflammatory pathways.
- Highlights the significance of oxidative stress and subclinical inflammation as therapeutic targets for T2DM.
- Suggests novel approaches for the prevention and management of Type 2 diabetes mellitus, potentially improving patient outcomes.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
